Aeolus Pharmaceuticals Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
281.00
869.00
1,517.00
94.00
3,155.00
Total Accounts Receivable
882.00
370.00
1,559.00
1,585.00
750.00
Other Current Assets
61.00
39.00
46.00
45.00
230.00
Total Current Assets
1,224.00
1,278.00
3,122.00
1,724.00
4,135.00
Total Investments and Advances
32.00
32.00
32.00
32.00
32.00
Other Assets
-
656.00
426.00
21.00
-
Total Assets
1,256.00
1,966.00
3,580.00
1,777.00
4,167.00
ST Debt & Current Portion LT Debt
-
-
-
1,002.00
-
Accounts Payable
2,272.00
579.00
1,552.00
1,598.00
972.00
Other Current Liabilities
-
682.00
443.00
22.00
-
Total Current Liabilities
2,272.00
1,261.00
1,995.00
2,622.00
972.00
Other Liabilities
19,319.00
-
-
-
-
Total Liabilities
21,591.00
1,261.00
1,995.00
2,622.00
972.00
Common Equity (Total)
20,340.00
700.00
1,580.00
850.00
3,195.00
Total Shareholders' Equity
20,335.00
705.00
1,585.00
845.00
3,195.00
Total Equity
20,335.00
705.00
1,585.00
845.00
3,195.00
Liabilities & Shareholders' Equity
1,256.00
1,966.00
3,580.00
1,777.00
4,167.00
Preferred Stock (Carrying Value)
5.00
5.00
5.00
5.00
-
About Aeolus Pharmaceuticals
View Profile
